Cargando…
Pharmacogenetics of taxane‐induced neurotoxicity in breast cancer: Systematic review and meta‐analysis
Taxane‐based chemotherapy regimens are used as first‐line treatment for breast cancer. Neurotoxicity, mainly taxane‐induced peripheral neuropathy (TIPN), remains the most important dose‐limiting adverse event. Multiple genes may be associated with TIPN; however, the strength and direction of the ass...
Autores principales: | Guijosa, Alberto, Freyria, Ana, Espinosa‐Fernandez, Jose Rodrigo, Estrada‐Mena, Francisco J., Armenta‐Quiroga, Ana Sofía, Ortega‐Treviño, Maria Fernanda, Catalán, Rodrigo, Antonio‐Aguirre, Bani, Villarreal‐Garza, Cynthia, Perez‐Ortiz, Andric C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579387/ https://www.ncbi.nlm.nih.gov/pubmed/35892315 http://dx.doi.org/10.1111/cts.13370 |
Ejemplares similares
-
Pharmacogenetics of response to neoadjuvant paclitaxel treatment for locally advanced breast cancer
por: Perez-Ortiz, Andric C., et al.
Publicado: (2017) -
Taxane-Induced Peripheral Neurotoxicity
por: Velasco, Roser, et al.
Publicado: (2015) -
Adjuvant therapy of endometrial cancer: “taxane or not taxane, this is the question”
por: Lorusso, Vito, et al.
Publicado: (2019) -
CD47-SIRPα Axis as a Biomarker and Therapeutic Target in Cancer: Current Perspectives and Future Challenges in Nonsmall Cell Lung Cancer
por: Catalán, Rodrigo, et al.
Publicado: (2020) -
Characterization of triple negative breast cancer gene expression profiles in Mexican patients
por: Ortiz Valdez, Eric, et al.
Publicado: (2022)